🇺🇸 FDA
Patent

US 8642048

Multiple antigenic peptides immunogenic against Streptococcus pneumonia

granted A61KA61K38/00A61K39/00

Quick answer

US patent 8642048 (Multiple antigenic peptides immunogenic against Streptococcus pneumonia) held by The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Grant date
Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K38/00, A61K39/00, A61P, A61P37/04